With nothing else to do at 3am..except try to find out why Shane is not here and how much more pharmaceutical corruption it will take before someone somewhere will take responsibility and stop this madness, it didn’t take much googling to find some dubious activities from lundbeck. From allegations of medical fraud and bribery, hidden advertising to European Commission investigations, it baffles me as to how pharmaceutical companies seem to escape the law.
Valby-based pharmaceutical company admits the European Commission is investigation its activities
The European Commission is scrutinising pharmaceutical company Lundbeck for allegedly preventing other producers from making generic brands of its antidepressant Cipramil.
According to a statement from the commission, it will examine whether Lundbeck has tried to prevent companies such as Israeli manufacturer Teva – the world’s largest producer of generic drugs – from launching cheaper versions of Citalopram, the active substance in Lundbeck’s Cipramil and Celexa
Lundbeck’s patent on the substance has long expired and the company has since developed a newer patented substance for its antidepressants called Escitalopram.
According to Bloomberg News, officials from the commission searched Lundbeck and Teva offices in December in connection with the allegations. The news agency reports this was the fourth time since January 2008 the commission has raided offices of pharmaceutical companies.
The commission’s actions are a result of a report published last year by the commission’s competition unit, which found that considerable problems exist within the pharmaceutical industry – particularly when it comes to original manufacturers’ attempts to fight off generic copies of drugs they developed, but whose patents have expired.
At Lundbeck, head of communications Mads Kronborg stressed that the investigation did not mean the commission was bringing official charges against the company.
Depression advice website seems to promote products made by pharmaceutical company Lundbeck
Lundbeck has been accused of hidden advertising after it has emerged that the pharmaceutical company is behind a popular internet forum for people suffering depression.
An episode of public broadcaster DR’s 21 SØNDAG showed that the Lundbeck Institute – a non-commercial operation founded by Lundbeck – operates the website DepNet.dk.
The forum provides information about depression and thousands of reader queries are answered by medical professionals on the website.
DR examined more than 500 letters that had been answered by doctors and psychiatrists on the website and found that medication manufactured by Lundbeck was mentioned in 44 percent of the answers.
The Copenhagen post, 04 February 1999
Ten years after the anti-depressive medicine Cipramil was first approved for sale on the Danish market, concern has arisen over both its approval and the effectiveness of this widely used drug. This week researchers and doctors have begun to question whether or not experts here were too hasty when they approved Cipramil for sale in Denmark in1989. Allegations of medical fraud and bribery have been made as well as claims that the scientific and medical research carried out on the now popular anti-depressant was not thorough enough to allow the drug to be administered to patients suffering from depression.
Special Consultant Carl Hugod has taken the current concerns one step further and in a surprising move has lodged a complaint concerning the scientific research material with the committee that deals with scientific fraud.
A DR radio documentary last Tuesday evening claimed that the National Board of Health committee that approves drugs for sale here was incapable of making a fair and unbiased decision because several committee members had accepted research funds from the Lundbeck Foundation. The Lundbeck Foundation owns H Lundbeck A/S, which produces Cipramil. The programme also declared that Carl Hugod had examined the research material that led to the drug’s approval by the committee, and found that a large percentage of the necessary material was not available.
“In my opinion the National Board of Health should never have been satisfied with this utterly disgraceful lack of scientific documentation concerning the drug’s effectiveness.” Said Hugod
4. Lundbeck breaks advertising rules…
In 2003, an article in the British Medical Journal (BMJ) stated that the Danish drug company Lundbeck was found by the drug industry’s watchdog to have breached the UK industry code of practice in the way it advertised the successor to its top selling product, the antidepressant citalopram (Cipramil). The company claimed that its new offering, escitalopram (Cipralex), was more effective than citalopram, even though the two drugs have exactly the same active ingredient. Link